Purpose
The Pediatric Quality of Life (PedsQL) Measurement Model is a modular approach to measuring health-related quality of life (HRQOL) in healthy children and adolescents and those with acute and chronic health conditions.
Link to Instrument
https://eprovide.mapi-trust.org/instruments/pediatric-quality-of-life-inventory-generic-core-scales
Area of Assessment
Quality of LifeLife Participation
Social Relationships
Mental Health
Assessment Type
Patient Reported OutcomesAdministration Mode
Paper & PencilCost
Not FreeActual Cost
$0.00Cost Description
Free for not funded academic research.Not free for funded academic research, large non-commercial organization research & evaluation (i.e., states, hospitals or healthcare systems), or commercial use.
Cost varies depending on use type. Full cost structure can be found here: https://www.pedsql.org/PedsQL-CostStructure.pdf.
CDE Status
NINDS CDE Notice of Copyright
PedsQL *Searched on 8/13/2022
Availability | Please visit these websites for more information about the instrument: PedsQL or ePROVIDE |
Classification | NeuroRehab Core: Pediatric (ages 2-18) Supplemental - Highly Recommended: Mitochondrial Disease (Mito) and Sport-Related Concussion (SRC) Subacute (after 72 hours to 3 months) Supplemental: Cerebral Palsy (CP), Duchenne Muscular Dystrophy (DMD), Friedreich's Ataxia (FA), Headache, Spinal Muscular Atrophy (SMA), SRC Acute (time of injury until 72 hours) and Persistent/Chronic (3 months and greater post concussion), Stroke, Acute, Moderate and Mild Traumatic Brain Injury (TBI), and Epidemiology TBI Exploratory: Myotonic Dystrophy (DM) |
NINDS CDE Highlight Summaries (searched on 8/9/2023)
NeuroRehab
- Outcomes and Endpoints/Pediatric: NeuroRehab Core
Spinal Muscular Atrophy (SMA)
- Outcomes and Endpoints/Quality of Life: Supplemental
Myotonic Dystrophy
- Outcomes and Endpoints/Pediatric: Exploratory
Duchenne Muscular Dystrophy (DMD)/Becker Muscular Dystrophy (BMD)
- Outcomes and Endpoints/Quality of Life: Supplemental
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
- Outcomes and Endpoints/Fatigue: Supplemental
Mitochondrial Disease
- Supplemental – Highly Recommended
Headache Version 2.0
- Outcomes and Endpoints/Quality of Life: Supplemental
Friedreich’s Ataxia (FA)
- Outcomes and Endpoints/Quality of Life: Supplemental
Stroke
- Outcomes and Endpoints/Pediatric: Supplemental